PUBLISHER: IMARC | PRODUCT CODE: 1635984
PUBLISHER: IMARC | PRODUCT CODE: 1635984
The global veterinary point of care blood gas analyzers market size reached USD 66.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 93.0 Million by 2033, exhibiting a growth rate (CAGR) of 3.69% during 2025-2033. The widespread adoption of companion animals, the growing consumer awareness regarding the importance of livestock health, and the increasing need for point of care testing (POCT) represent some of the key factors driving the market.
Veterinary point of care (PoC) blood gas analyzer are compact handheld devices typically used in veterinary clinics for point of care blood testing. Point of care blood gas analyzers are considered as advanced solutions to evaluate the potential of hydrogen (PH) levels, electrolytes, blood gases metabolites, and various diseases. They offer convenience of usage with better clinical results and therefore find extensive applications in clinics, research centers, and laboratories. Veterinary PoC blood gas analyzers are widely used in veterinary centers and research laboratories dealing with animal health concerns.
Steadily increasing pet ownership represents one of the key factors driving the market growth. In line with this, the widespread adoption of companion animals, such as canines, cats, and rabbits, especially by nuclear families, are driving the market growth. The rising awareness regarding the importance of animal health is acting as another growth-inducing factor. Moreover, the increasing demand for POC testing systems over laboratory testing solutions to detect multiple zoonotic diseases instantly with better clinical outcomes are supporting the market growth. PoC testing systems help analyze multiple disorders, including ringworm, pox, piglet diarrhea, scour, rabies, black quarter, and other ailments amongst companion animals in a rapid and more effective manner, which is positively supporting the market growth. Additionally, the favorable initiatives undertaken by governments of several nations to allow the rapid establishment of veterinary clinics and equip them with advanced medical systems are contributing to the market growth. Furthermore, the escalating infection rate amongst pet animals, especially during the COVID-19 pandemic and the enforcement of nationwide lockdowns, facilitated the demand for residential PoC testing, which can be performed at home. This, in turn, is favoring the market growth significantly. This can be further attributed to significant technological advancements in the existing healthcare systems in terms of results, accuracy, ease of handling, efficacy, and convenience. Other factors, such as the recent improvements in the healthcare infrastructure, the continuous research and development (R&D) activities, and strategic collaborations amongst key players to engineer new PoC blood gas analyzers, are creating a positive outlook for the market.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.